Age: 38.0
Sex: F
Vaccine: HPV4
Symptoms: Impaired work ability, Insomnia, Loss of personal independence in daily activities, Mobility decreased, Musculoskeletal stiffness
Clinical narrative: nerve pain/neurological dysfunction/neurological disease/neurological injuries; tremors; stuttering; tinnitus; eye floaters; burning sensation on her arms and hands/neurological dysfunction/neurological disease/neurological injuries; autonomic injuries/autonomic dysfunction/autonomic disease; vision problems; low body temperature; numbing sensation on her arms and hands; autoimmune dysfunction/ autoimmune disease/ autoimmune injuries; neck stiffness; mold allergy/headaches/allergies to certain environments; gluten allergy/nausea/fatigue/headaches/brain fog/stomach pain/anxiety/allergies to certain foods; chronic fatigue syndrome/intensely painful headaches/anxiety/insomnia/body aches/fatigue/extreme weakness/light sensitivity/chronic headaches/stomach pain/joint pain/short-term memory loss; Information has been received from a lawyer regarding a case in litigation and refers to an adult female patient (exact age was not provided). Her concurrent conditions, medical history and concomitant therapies were not provided. On 11-NOV-2020, at the age of 38 years old, the patient was vaccinated with the first dose of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) intramuscular injection (exact dose, route of administration, anatomical location, lot # and expiration date were not provided), as recommended by her physician. The patient experienced serious and debilitating injuries, including but not limited to autonomic, autoimmune, and neurological injuries and resulting sequalae that the patient sustained as a result of receiving the Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) vaccine. On an unknown date, reported as after receiving her first and only Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) vaccination, the patient was rushed to the Emergency Room due to intensely painful headaches. She also experienced nausea, anxiety, insomnia, heart palpitations, nerve pain, body aches, tremors, brain fog, and stuttering. In addition, the patient experienced low body temperature, fatigue, extreme weakness, and vision problems resulting in light sensitivity and chronic headaches. On unknown dates, she was rushed to the Emergency Room two more times for tinnitus, eye floaters, ear pain, pelvic pain, stomach pain, joint pain, back pain, neck stiffness, and short-term memory loss. The patient also experienced a numbing and burning sensation on her arms and hands, difficulty standing up, light-headedness from standing up, heart palpitations, and weakness. Her symptoms worsened over time resulting in her being unable to get out of bed for days or physically carry out simple daily tasks. The patient also began suffering allergies to certain foods and environments. She was diagnosed with chronic fatigue syndrome in March 2021 and with mold and gluten allergies in September 2022. As the months progressed, so did the patient's symptoms. She was seen by multiple physicians and specialists for her complaints which now included: painful headaches, nausea, anxiety, insomnia, heart palpitations, nerve pain, body aches, tremors, brain fog, stuttering, low body temperatures, fatigue, weakness, vision problems that resulted in light sensitivity, chronic headaches, tinnitus, eye floaters, ear pain, pelvic pain, stomach pain, joint pain, back pain, neck stiffness, short-term memory loss, numbing and burning sensation on her arms and hands, difficulty standing up, light-headedness from standing up, heart palpitations, and weakness. The patient was unable to engage in activities that she would typically was able to do before receiving the Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) injection. As a result of her post Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) symptoms, her ability to engage in normal daily activities, including caring for her children, has been severely impacted, as well as her career, which she ultimately had to quit. Based upon her chronic and severe post- Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) symptoms, the patient was diagnosed with various medical conditions, including but not limited to, chronic fatigue syndrome, mold allergy, and gluten allergy. Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) caused her to develop serious and debilitating autoimmune, autonomic, and neurological injuries, including but not limited to chronic fatigue syndrome, mold allergy, and gluten allergy, as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which were alleged herein and all of which were caused by Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) or otherwise linked to her Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL)-induced autoimmune disorder. As a proximate result of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL), the patient suffered and continued to suffer severe and permanent physical injuries and associated symptomology and has suffered severe and permanent emotional injuries, including pain and suffering. The patient also had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of future symptoms and harms associated with her autoimmune disease and other injuries caused by Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL). As a direct and proximate result of her Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL)-induced injuries, the patient suffered and continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity, and she would continue to incur these losses and expenses in the future. The outcome of the events was considered to be not recovered. The reporter considered the events to be related to quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL).  Upon internal review, the event of autoimmune disorder was determined to be medically significant. The reporter considered all events to be disabling.